TORONTO, ON / ACCESS Newswire / May 15, 2025 /AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), ... Appointment brings public policy expertise, strategic insight, and ...

TORONTO, ON / ACCESS Newswire / May 15, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a developer of AI-based signal processing technologies for ...

New board‑level committee will steer regulatory strategy, IP development, and product innovation across AIML's AI‑driven health‑tech portfolio TORONTO, ON / ACCESS Newswire / May 22, 2025 / AI/ML ...

TORONTO, ON / ACCESS Newswire / May 15, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a developer of AI-based signal processing technologies for healthcare ...

TORONTO, ON / ACCESS Newswire / May 20, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQBAIMLF)(FWB:42FB) today announced the establishment of its Medical Advisory Board ...

Medical Advisory Board will guide clinical studies, regulatory strategy, and global adoption of AIML's AI‑driven ECG signal‑processing solutions MaxYield™ and CardioYield™ across wearables and ...

Medical Advisory Board will guide clinical studies, regulatory strategy, and global adoption of AIML's AI-driven ECG signal-processing solutions MaxYield and CardioYield across wearables and cardiolog ...